Market Closed -
Other stock markets
|
After market 10:15:41 pm | |||
12.66 EUR | -0.47% |
|
12.68 | +0.16% |
10:55am | Abivax: phase 3 data delayed to Q2 2025 | CF |
15/07 | Abivax SA Provides Updates on Ongoing Clinical Trials | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.92% | 874M | |
+25.23% | 46.56B | |
+45.38% | 41.67B | |
+0.35% | 41.16B | |
+33.02% | 32.4B | |
+21.03% | 28.18B | |
-6.35% | 28.1B | |
+48.97% | 14.52B | |
+47.52% | 13.74B | |
+3.20% | 12.17B |
- Stock Market
- Equities
- ABVX Stock
- News Abivax
- Transcript : ABIVAX Société Anonyme Presents at JPMorgan 40th Annual Healthcare Conference, Jan-13-2022 12